DSM B.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
11 mar 2014 - 19:00
Statutory name
DSM B.V.
Title
Royal DSM and JLL Partners Create DPx; USD 2.65 billion transaction to create global CDMO leader successfully completed
Comments
JLL Partners (JLL), the middle-market private equity firm, and Royal DSM (Euronext: DSM KON), the global Life Sciences and Materials Sciences company, today announced the successful closing of the transaction announced in November 2013 combining DSM Pharmaceutical Products (DPP) and Patheon Inc. into a new privately held company, named DPx Holdings B.V. (DPx). As of today, DPx, a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry with anticipated sales of around USD 2 billion (pro-forma), a strong EBITDA and operational cash flow and more than 8,000 employees, will become operational.
Related downloads
Date last update: 14 May 2026